ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9

SAN DIEGO, Feb. 2  /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010, at 10:30 a.m. Eastern time, in the Park South room at the Waldorf Astoria in New York.  The conference is being hosted by the Biotechnology Industry Association.

Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/.  An archived presentation will be available on the Web site for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the performance of existing cancer treatments by addressing limitations associated principally with their safety and use.  More information can be found on the Company's Web site at http://www.adventrx.com/. 

DATASOURCE: ADVENTRX Pharmaceuticals, Inc.



CONTACT:  Brian Culley, Principal Executive Officer of ADVENTRX

Pharmaceuticals, [phone]; or Investors, Don Markley of

Lippert/Heilshorn & Associates, Inc., [phone],  , for

ADVENTRX Pharmaceuticals



Web Site:  http://www.adventrx.com/ 

Copyright